Nicholas E. Hagemeier

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis”.

Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis

Journal of the American Pharmacists Association(2020)10.1016/j.japh.2020.06.008

N/A

0DataRank · unranked

18 citations

Nicholas E. Hagemeier, Fred Tudiver, KariLynn Dowling-McClay, Kelly N. Foster, Jessie Arnold +3 more

Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists

Addiction Science & Clinical Practice(2024)10.1186/s13722-024-00519-w

N/A

0DataRank · unranked

3 citations

Jacquie King, Kathryn Hefner, Mark Schactman, William S. John, Nicholas E. Hagemeier +4 more

A theoretical explanation of naloxone provision among primary care physicians and community pharmacists in Tennessee

Research in Social and Administrative Pharmacy(2024)10.1016/j.sapharm.2024.07.001

N/A

0DataRank · unranked

0 citations

Stephanie M. Mathis, Bill Brooks, Nicholas E. Hagemeier, Fred Tudiver, Kelly N. Foster +3 more